Friday, February 19, 2016

Weekly Links February 19th, 2016



“MUST READ”
An old problem in a new age: Revisiting the clinical dilemma of misattributed paternity Clinical genetics has wrestled with the problem of misattributed paternity for decades. While there are no clear directives on policy, surveys suggest that gen…
Interview With President Barack Obama : Popular Science PS: Let’s talk about more-difficult science: Two of your biggest science initiatives have been to decode the brain and pioneer precision medicine.
TOOLS/TECHNIQUES
    • NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today presented the first proof-of-concept data for its novel massively parallel single molecule sequencing chemistry, Hyb & SeqTM, at the Advances in Genome Biology and Technology (AGBT) Meeting
  • World Largest Genome Project & Global Leader in NGS Partner
World’s Largest Genome Sequencing Project partners with Global Leader in NGS Genomics England (UK) today announce a partnership with the Next-Generation Sequencing Giant, Illumina (US), to develop a platform that can be used to improve and automate …

HEALTH/MEDECINE
Human Complex Trait Genetics in the 21st Century I moved into the field of human complex trait genetics less than 20 years ago, from a background in quantitative genetics and animal breeding. Even in this period of time, major changes have occurred …

COMPANIES
    • Millidrop will use the fund to start producing trial runs of its first machine, the MilliDrop Analyzer. This machine uses millifluidics technology to culture and analyse micro-organisms.
The company is also under the Pierre-Gilles de Gennes Institute for Microfluidics (IPGG), which is serving as an incubator for MilliDrop.
At-Home Full Genome-Sequencing Is Now Just A Spit Tube Away DNA sequencing startup Sure Genomics wants to help you learn about your entire genome at the click of a button. Today, the startup opened up an at-home service to the public, enabling consu…

No comments:

Post a Comment